National Cancer Institute; Notice of Meeting, 11280 [2016-04671]

Download as PDF 11280 Federal Register / Vol. 81, No. 42 / Thursday, March 3, 2016 / Notices Basis Upon Which Winner Will Be Selected The review panel will make selections based upon the following criteria: Phase 1 • Technical feasibility of plan, including number of EHR sources targeted. • Adherence to data privacy and security best practices. • Strength of business/sustainability plan. • Provider and/or health IT developer partnerships. Phase 2 • Number, sources, and types of data aggregation using FHIR. • Functionality and quality of data aggregation. • Privacy and security of patient data. • User experience and visual appeal. Additional Information General Conditions: ONC reserves the right to cancel, suspend, and/or modify the Contest, or any part of it, for any reason, at ONC’s sole discretion. Intellectual Property: Each entrant retains title and full ownership in and to their submission. Entrants expressly reserve all intellectual property rights not expressly granted under the challenge agreement. By participating in the challenge, each entrant hereby irrevocably grants to Sponsor and Administrator a limited, non-exclusive, royalty-free, worldwide license and right to reproduce, publically perform, publically display, and use the Submission to the extent necessary to administer the challenge, and to publically perform and publically display the Submission, including, without limitation, for advertising and promotional purposes relating to the challenge. Authority: 15 U.S.C. 3719. Dated: February 23, 2016. Karen DeSalvo, National Coordinator for Health Information Technology. [FR Doc. 2016–04596 Filed 3–1–16; 11:15 am] BILLING CODE 4150–45–P mstockstill on DSK4VPTVN1PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the VerDate Sep<11>2014 19:17 Mar 02, 2016 Jkt 238001 National Cancer Advisory Board Ad Hoc Subcommittee on Global Cancer Research. The teleconference meeting will be open to the public. Name of Committee: National Cancer Advisory Board; Ad Hoc Subcommittee on Global Cancer Research. Date: March 23, 2016. Time: 2:00 p.m. to 3:00 p.m. Agenda: Preview global cancer research outline for presentation at the June 2016 Joint BSA and NCAB Meeting. Place: National Cancer Institute, Shady Grove Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850, (Telephone Conference Call)—Dial in number: 1–866– 692–3158 and Passcode: 9875262. Contact Person: Edward T. Trimble, M.D., M.P.H., Executive Secretary, NCAB Ad Hoc Subcommittee on Global Cancer Research, Director, Center for Global Health, National Cancer Institute—Shady Grove, National Institutes of Health, 9609 Medical Center Drive, Room 3W562, Bethesda, MD 20892, 240–276–5796, trimblet@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: February 29, 2016. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–04671 Filed 3–2–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning PO 00000 Frm 00108 Fmt 4703 Sfmt 4703 individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Neurological Epidemiology. Date: March 10, 2016. Time: 9:30 a.m. to 11:30 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Valerie Durrant, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3148, MSC 7770, Bethesda, MD 20892, (301) 827– 6390, durrantv@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Pregnancy and Neonatology. Date: March 23, 2016. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Antonello Pileggi, M.D., Ph.D., Scientific Review Officer, Center for Scientific Review, National Institute of Heath, 6701 Rockledge Drive, Room 6166, Bethesda, MD 20892–7892, (301) 402–6297, pileggia@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Regeneration and Developmental Biology. Date: March 23, 2016. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Raya Mandler, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5217, MSC 7840, Bethesda, MD 20892, 301–402– 8228, rayam@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Basic Research on HIV Persistence. Date: March 24, 2016. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: The Fairmont Washington, DC, 2401 M Street NW., Washington, DC 20037. Contact Person: Kenneth A. Roebuck, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5106, MSC 7852, Bethesda, MD 20892 (301) 435– 1166, roebuckk@csr.nih.gov. Name of Committee: AIDS and Related Research Integrated Review Group; AIDSassociated Opportunistic Infections and Cancer Study Section. Date: March 25, 2016. Time: 8:00 a.m. to 6:00 p.m. E:\FR\FM\03MRN1.SGM 03MRN1

Agencies

[Federal Register Volume 81, Number 42 (Thursday, March 3, 2016)]
[Notices]
[Page 11280]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-04671]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
National Cancer Advisory Board Ad Hoc Subcommittee on Global Cancer 
Research.
    The teleconference meeting will be open to the public.

    Name of Committee: National Cancer Advisory Board; Ad Hoc 
Subcommittee on Global Cancer Research.
    Date: March 23, 2016.
    Time: 2:00 p.m. to 3:00 p.m.
    Agenda: Preview global cancer research outline for presentation 
at the June 2016 Joint BSA and NCAB Meeting.
    Place: National Cancer Institute, Shady Grove Shady Grove, 9609 
Medical Center Drive, Rockville, MD 20850, (Telephone Conference 
Call)--Dial in number: 1-866-692-3158 and Passcode: 9875262.
    Contact Person: Edward T. Trimble, M.D., M.P.H., Executive 
Secretary, NCAB Ad Hoc Subcommittee on Global Cancer Research, 
Director, Center for Global Health, National Cancer Institute--Shady 
Grove, National Institutes of Health, 9609 Medical Center Drive, 
Room 3W562, Bethesda, MD 20892, 240-276-5796, trimblet@mail.nih.gov.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: February 29, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-04671 Filed 3-2-16; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.